New immunotherapy combination shows promise for patients with advanced melanoma
Treatment with a combination of ipilimumab (Yervoy) and Coxsackievirus A21 (CVA21; Cavatak) led to durable…
Treatment with a combination of ipilimumab (Yervoy) and Coxsackievirus A21 (CVA21; Cavatak) led to durable…
Treatment with the immune checkpoint inhibitor nivolumab (Opdivo) yielded durable responses in some patients with…
University of Colorado Cancer Center researchers presented the results of a phase II clinical trial…
Among patients with advanced melanoma, those who received both nivolumab (Opdivo) and ipilimumab (Yervoy) had…
Researchers found similar rates of disease-free survival and no difference in overall survival among women…
Among healthy postmenopausal women, supplementation with vitamin D3 and calcium compared with placebo did not…
What if you could plaster cancer cells with glowing “Here We Are” signs, so surgeons…
Bisphenol S (BPS), a substitute for the chemical bisphenol A (BPA) in the plastic industry,…
A new analysis of patients who have undergone treatment for prostate cancer shows a connection…
Patients with glioblastoma who wore a medical device that delivers alternating electrical fields in addition…